In April 2024, Beforpharma initiated a partnership with the boutique financial agency, BizPlace, based in Rome. As part of this collaboration, BizPlace will assist Beforpharma in preparing for its initial round of investments in Italy, a key component of the company’s expansion strategy.
The goal of this investment round is to facilitate the company’s organizational development in order to foster growth and streamline transitioning to large-scale production of radiopharmaceutical products in the upcoming years. The company aims to raise around 1.5 million euros in funding in this first stage.
Beforpharma, established in 2014, is an innovative SME specializing in providing radiopharmaceutical services to both private and public entities and medical institutions within the nuclear medicine field. For further details, please reach out to Beforpharma’s CEO Roberto La Forgia at [email protected].